ASTON SCI Trademark

Trademark Overview


On Tuesday, May 30, 2023, a trademark application was filed for ASTON SCI with the United States Patent and Trademark Office. The USPTO has given the ASTON SCI trademark a serial number of 98018774. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, March 27, 2024. This trademark is owned by ASTON Sci. Inc.. The ASTON SCI trademark is filed in the Pharmaceutical Products category with the following description:

Pituitary hormone preparations; pharmaceutical preparations for immunity adjustment; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; biochemical preparations for the treatment of tumor or immunologic disease; cells for medical purposes; blood for medical purposes; chemical preparations for the treatment of tumor or immunologic disease; human plasma protein; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of tumor or immunologic disease; pharmaceutical preparations acting on the central nervous system; tumor suppressing agents
aston sci

General Information


Serial Number98018774
Word MarkASTON SCI
Filing DateTuesday, May 30, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, March 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPituitary hormone preparations; pharmaceutical preparations for immunity adjustment; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; biochemical preparations for the treatment of tumor or immunologic disease; cells for medical purposes; blood for medical purposes; chemical preparations for the treatment of tumor or immunologic disease; human plasma protein; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of tumor or immunologic disease; pharmaceutical preparations acting on the central nervous system; tumor suppressing agents
Disclaimer with Predetermined Text"SCI"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameASTON Sci. Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul 06193
KR

Trademark Events


Event DateEvent Description
Wednesday, March 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 22, 2024NON-FINAL ACTION E-MAILED
Thursday, February 22, 2024NON-FINAL ACTION WRITTEN
Wednesday, February 21, 2024ASSIGNED TO EXAMINER
Wednesday, June 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 2, 2023NEW APPLICATION ENTERED